PMV Pharmaceuticals (PMVP)

• Market cap: $65.5M
• 1 day: -4.65%
• 5 days: -8.89%
• 1 month: -12.14%
• 3 months: -17.45%
• 6 months: 40.25%
• Year to date: -19.61%
• 1 year: -27.22%
• 5 years: -96.66%
• 10 years: -96.72%
• Sector: Healthcare
• Industry: Biotechnology

About: PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Employees: 47